← Leaderboards
Kendell Marleen Pawelec
Fibrosix, Llc
$302,500
Attributed
$302,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2018–20$500K$375K$250K$125K$0
'18
'19
'20
Funding mix
By agency
NIH$302,500 · 1
By mechanism
R43$302,500 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Achievement”
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
- Joy Williamson-Lott · University Of Washington$69,987,326
- Tony Moody · Duke University$59,183,249
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Robert Coughlin · Harvard University$50,428,432
Research focus
AchievementAdvanced DevelopmentAdrenal Cortex HormonesAmes AssayBaseBiochemicalBiological AvailabilityBiotechnologyBleomycinBloodCancer PatientCapitalChemotherapyChemotherapy-Oncologic ProcedureClinicCollagenCommercial ApplicationContractorDesignDiagnosisDisease RemissionDoseDrug KineticsDrug Targeting
Grant awards (2)
Demonstrating the feasibility of CCG-257081 as a preventive therapy to inhibit bleomycin-induced lung fibrosis in mice$2,500
R43 · FY2020 · CA · contact PI
Demonstrating the feasibility of CCG-257081 as a preventive therapy to inhibit bleomycin-induced lung fibrosis in mice$300,000
R43 · FY2018 · CA · contact PI